Historically, patients diagnosed with castration-resistant prostate cancer (CRPC) have had poor survival rates. In recent years there have been significant advances in the treatment of CRPC. In ...
Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Thomas Barwick / Getty Images The chartered retirement planning counselor® (CRPC) ...
Androgen deprivation is the mainstay of advanced prostate cancer treatment. Despite initial responses, almost all patients progress to castration-resistant prostate cancer (CRPC). The understanding of ...
Feasibility of RNA sequencing to detect TMPRSS2:ERG fusions following laser capture microdissection of prostate cancer. This is an ASCO Meeting Abstract from the 2013 Genitourinary Cancers Symposium.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results